With interest in scaled home health assets climbing among strategic buyers, few, if any, large home health companies are likely to stay independent, according to Amedisys CEO Paul Kusserow.
Kusserow made these remarks at a dinner hosted by Jefferies Financial Group, Home Health Care News reports.
Recent home health transactions lend credence to these observations — Humana’s $5.7 billion acquisition of a 100% stake in Kindred at Home and Optum Health’s pending purchase of LHC Group for $5.5 billion. Optum is a subsidiary of UnitedHealth Group (NYSE: UHN).
Deals like these allow payers to capitalize on growing demand for home-based care and move more patients into a lower cost setting. They also present an opportunity to better manage the financial risk associated with value-based reimbursement systems. Read more.
